Hearing Screening and Diagnostic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028
세계 청력 검사 및 진단 기기 시장 규모는 2023년부터 2028년까지 예측 기간 동안 6.73%의 CAGR을 나타낼 것으로 예상됩니다. 청력 검사 및 진단에 대한 수요는 주로 청각 장애, 유전성 질환, 출생 시 합병증과 같은 다양한 요인으로 인한 난청 사례 증가에 의해 촉진되고 있습니다., 청력 질환의 조기 발견에 대한 수요 증가로 이어지는 다양한 정부 이니셔티브를 통해 청력 장애 진단 및 치료에 대한 인식이 높아지면서 2023-2028년의 예측 기간 동안 청력 검사 및 진단 기기 시장의 성장에 기여하고 있습니다.
세계보건기구(WHO)가 2023년 발표한 자료에 따르면, 2050년까지 세계 약 25억 명이 어느 정도의 난청을 겪게 될 것으로 추정됩니다. 이 자료에 따르면 2050년까지 10명 중 1명이 난청을 겪게 될 것으로 추정됩니다. 이처럼 난청과 같은 다양한 요인으로 인한 난청 유병률 증가는 청력 장애에 대한 선별 및 진단의 필요성을 창출하여 청력 선별 및 진단 기기 시장의 긍정적인 성장을 가져옵니다.
또한, 보다 정확하고 효율적인 청력 검사 및 진단 기기의 개척으로 이어지는 기술 발전 증가, 제품의 신흥 시장 증가 및 승인은 청력 검사 및 진단 기기 시장의 긍정적인 성장에 영향을 미치는 다른 요인 중 일부입니다.
그러나 청력 검사 및 선별 장비와 관련된 높은 비용, 신흥국 시장에서 정기적인 청력 검사의 중요성에 대한 인식과 교육의 부족은 청력 검사 및 진단 기기 시장의 성장을 제한할 수 있는 주요 억제요인으로 작용하고 있습니다.
이 보고서는 세계 청력 검사 및 진단 기기 시장을 조사했으며, 시장 개요와 함께 제품별, 적응증별, 최종 사용자별, 지역별 동향, 시장 진출기업 프로파일 등을 제공합니다.
목차
제1장 청각 검사 및 진단 기기 시장 보고서 서론
제2장 청각 검사 및 진단 기기 시장 주요 요약
제3장 규제 분석
제4장 청각 검사 및 진단 기기 시장 주요 요인 분석
- 청각 검사 및 진단 기기 시장 성장 촉진요인
- 청각 검사 및 진단 기기 시장 성장 억제요인과 과제
- 청각 검사 및 진단 기기 시장 기회
제5장 청각 검사 및 진단 기기 시장 Porter의 Five Forces 분석
제6장 청각 검사 및 진단 기기 시장 개요
제7장 청각 검사 및 진단 기기 시장 기업 및 제품 개요
- Amplivox
- Otodynamics Ltd.
- INVENTIS s.r.l.
- Intelligent Hearing Systems
- Natus Medical Incorporated
- MAICO Diagnostics
- Path Medical Gmbh
- Interacoustics A/S
- Starkey Laboratories
- Vivosonic Inc.
- Welch Allyn
- Grason-Stadler Inc.
- Otometrics
- MedRx
- Medtronic
제8장 KOL(Key Opinion Leader)의 견해
제9장 프로젝트 접근
제10장 DelveInsight의 서비스 내용
제11장 DelveInsight에 대해
제12장 면책사항과 문의
LSH
Hearing Screening And Diagnostic Devices Market By Product (OAE/ABR Testing Devices, Audiometers, Otoscopes, And Tympanometers), Indication Type (Conductive Hearing Loss, Sensorineural Hearing Loss, And Combination Hearing Loss), End-User (Hospitals & Clinics, And Diagnostics Centers) and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of hearing loss due to hearing disorders, hereditary disorders, and birth complications.
The global Hearing Screening and Diagnostic Devices Market is estimated to grow at a CAGR of 6.73% during the forecast period from 2023 to 2028. The demand for screening and diagnosis of hearing is primarily being boosted by the increasing number of cases of hearing loss owing to various factors such as hearing disorders, hereditary disorders, and birth complications. Additionally, the rise in awareness of hearing defect diagnosis and treatment with various government initiatives, leading to higher demand for early detection of hearing diseases, is also contributing to the growth of the Hearing Screening and Diagnostic Device market during the forecast period from 2023-2028.
Hearing Screening And Diagnostic Devices Market Dynamics:
According to the data published by the World Health Organization (WHO) in 2023, it was estimated that nearly 2.5 billion people will be suffering from some degree of hearing loss by 2050, globally. According to the same source, it was estimated that 1 in every 10 people will have disabling hearing loss by 2050, globally. Thus the rising prevalence of hearing loss due to various factors such as hearing loss among others, will create a need for screening and diagnosis of hearing disorders, thus resulting in the positive growth of the Hearing Screening and Diagnostic Devices Market.
As per the statistics provided by the World Health Organization 2021, it was estimated that approximately 16% of hearing loss in adults results from exposure to excessive noise in the workplace, globally. Thus, increasing noise pollution is also one of the factors contributing to the increasing prevalence of hearing loss, which in turn will contribute to the growth of the Hearing Screening and Diagnostic Devices market.
Additionally, rising advancement in the technology leading to the development of more accurate and efficient hearing screening and diagnosis devices, and increase in product launches and approvals are some of the other factors influencing the positive growth of the Hearing Screening and Diagnostic Devices market.
However, the high cost associated with the hearing and screening devices, and lack of awareness or education regarding the importance of regular hearing screening in the developing nations, are some of the key constraints that may limit the growth of the Hearing Screening and Diagnostic Devices market.
Hearing Screening And Diagnostic Devices Market Segment Analysis:
Hearing Screening and Diagnostic Devices Market by Product (OAE/ABR Testing Devices, Audiometers, Otoscopes, and Tympanometers), Indication type (Conducting Hearing Loss, Sensorineural Hearing Loss, and Combination Hearing Loss), End-User (Hospitals & Clinics, and Diagnostic Centers) and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
The Audiometer category in the product types segment is estimated to account for a considerable revenue share in the Hearing Screening and Diagnostic Devices Market in 2022. This can be attributed to the various advantages provided by Audiometers in the domain of screening and diagnosis of various hearing disorders such as precise and controlled testing environments and allow healthcare professionals to assess a person's hearing sensitivity accurately. Additionally, the audiometers provide the ability for doctors to evaluate at different frequencies, thus helping in identifying specific areas of hearing loss. Thus, the various benefits provided by Audiometers will eventually contribute to the growth of the segment.
Furthermore, as the demand for this segment grows, novel products are being launched by various market players. For example, in November 2019, Interacoustics launched the AD528 Audiometer, an air, bone, and speech audiometer in the United States.
As a result of the aforementioned factors, the Audiometer segment is expected to grow significantly during the forecast period, consequently driving the expansion of the overall Hearing Screening and Diagnostic Devices Market.
North America is expected to dominate the overall Hearing Screening And Diagnostic Devices Market:
North America is expected to account for the highest proportion of the Hearing Screening and Diagnostic Devices Market in 2022, out of all regions. This is due to the presence of developed and sophisticated healthcare infrastructure, and the high prevalence of hearing disorders in the region. Additionally, the presence of key market players, attractive reimbursement policies, robust research and development initiatives, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Hearing Screening and Diagnostic Devices Market in North America.
According to statistics provided by National Council on Aging 2023, around 15.5% of adults 18 years and above, were suffering from some kind of hearing issues, during the period 2019 to 2022 in the United States. Thus, this indicates a huge need for hearing screening and diagnosis, therefore leading to the growth of the Hearing Screening and Diagnostic Devices market in the United States, which will further propel the Hearing Screening and Diagnostic Devices market in North America.
Additionally, the presence of key market players in the region such as Natus Medical Incorporated, Intelligent Hearing Systems, and Starkey Laboratories is another contributing factor responsible for the growth of the Hearing Screening and Diagnostic Devices market in North America.
Further, exemption from some regulatory steps during the process of product approvals from regulatory authorities is also aiding to the positive growth in Hearing Screening and Diagnostic Devices market in the region. For Instance, in January 2020, the US FDA exempted several hearing test devices from 510(k) premarket notification.
Therefore, the factors mentioned above, are thereby responsible for driving the North America Hearing Screening and Diagnostic Devices Market forward during the forecast period.
Hearing Screening And Diagnostic Devices Market Key Players:
Some of the key market players operating in the Hearing Screening and Diagnostic Devices market include: Amplivox, Otodynamics Ltd., INVENTIS s.r.l., Intelligent Hearing Systems, Natus Medical Incorporated, MAICO Diagnostics, Path Medical Gmbh, Interacoustics A/S, Starkey Laboratories, Vivosonic Inc., Welch Allyn, Grason-Stadler Inc., MedRx, and Medtronic.
Recent Developmental Activities in the Hearing Screening And Diagnostic Devices Market:
- In January 2023, Natus Medical Incorporated, acquired Micromed Holding SAS. The main objective of the acquisition was to expand Natus Medical's product portfolio as Micromed products will be added to Natus Medical's portfolio.
- In April 2019, Maico Diagnostics launched easyScreen with BERAphone®. The easyScreen unites AABR, OAE, and the patented technology of BERAphone. The technology helps achieve fast test times, as it is equipped with the patented CE Chirp® stimulus and response detection algorithm.
Key Takeaways from the Hearing Screening And Diagnostic Devices Market Report Study:
- Market size analysis for current Hearing Screening and Diagnostic Devices Market size (2022), and market forecast for 5 years (2023-2028)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
- Key companies dominating the global Hearing Screening and Diagnostic Devices market.
- Various opportunities available for the other competitors in the Hearing Screening and Diagnostic Devices Market space.
- What are the top-performing segments in 2022? How these segments will perform in 2028?
- Which are the top-performing regions and countries in the current Hearing Screening and Diagnostic Devices Market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Hearing Screening and Diagnostic Devices Market growth in the coming future?
Target Audience who can be benefited from this Hearing Screening And Diagnostic Devices Market Report Study:
- Hearing Screening and Diagnostic Devices product providers
- Research organizations and consulting companies
- Hearing Screening and Diagnostic Devices-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in Hearing Screening and Diagnostic Devices
- Various End-users who want to know more about the Hearing Screening and Diagnostic Devices Market and the latest technological developments in the Hearing Screening and Diagnostic Devices Market.
Frequently Asked Questions for the Hearing Screening And Diagnostic Devices Market:
1. What is meant by Hearing Screening and Diagnostic Devices?
- Hearing Screening and Diagnostic devices are used to assess the general hearing health of individuals. These provide a comprehensive assessment of an individual's hearing abilities and are employed to determine the type and the degree of hearing loss, as well as identify specific auditory disorders.
2. What is the market for global Hearing Screening and Diagnostic Devices?
- The global Hearing Screening and Diagnostic Devices Market is estimated to grow at a CAGR of 6.73% during the forecast period from 2023 to 2028.
3. What are the drivers for the global Hearing Screening and Diagnostic Devices market?
- The Hearing Screening and Diagnostic Devices Market is slated to witness prosperity owing to factors such as the growing prevalence of hearing loss, due to various factors such as hearing disorders, hereditary disorders, and birth complications. Additionally, the rise in awareness with various government initiatives, leading to higher demand for early detection of hearing disorders, and rising technological advancement and product launches in the domain, are some of the other factors resulting in appreciable revenue growth in the Hearing Screening and Diagnostic Devices Market during the forecast period (2023-2028).
4. Who are the key players operating in the global Hearing Screening and Diagnostic Devices market?
- Some of the key market players operating in the Hearing Screening and Diagnostic Devices Market Amplivox, Otodynamics Ltd., INVENTIS s.r.l., Intelligent Hearing Systems, Natus Medical Incorporated, MAICO Diagnostics, Path Medical Gmbh, Interacoustics A/S, Starkey Laboratories, Vivosonic Inc., Welch Allyn, Grason-Stadler Inc., MedRx, and Medtronic.
5. Which region has the highest share in the global Hearing Screening and Diagnostic Devices market?
- North America is expected to dominate the overall Hearing Screening and Diagnostic Devices Market during the forecast period, 2023 to 2028. This can be attributed to the presence of developed and sophisticated healthcare infrastructure and the high prevalence of hearing disorders in the region. Additionally, the presence of key market players, attractive reimbursement policies, robust research and development initiatives, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Hearing Screening and Diagnostic Devices Market in North America.
Table of Contents
1. Hearing Screening and Diagnostic Devices Market Report Introduction
2. Hearing Screening and Diagnostic Devices Market Executive Summary
- 2.1. Scope of the Study
- 2.2. Market at Glance
- 2.3. Competitive Assessment
3. Regulatory Analysis
- 3.1. The United States
- 3.2. Europe
- 3.3. Japan
- 3.4. China
4. Hearing Screening and Diagnostic Devices Market Key Factors Analysis
- 4.1. Hearing Screening and Diagnostic Devices Market Drivers
- 4.1.1. Increasing prevalence of hearing loss due to hearing disorders, hereditary disorders, and birth complications
- 4.1.2. Rising advancement in technology leading to the development of more accurate and efficient hearing screening and diagnosis devices
- 4.2. Hearing Screening and Diagnostic Devices Market Restraints and Challenges
- 4.2.1. High cost associated with hearing and screening devices
- 4.2.2. Lack of awareness or education regarding the importance of regular hearing screenings in developing nations
- 4.3. Hearing Screening and Diagnostic Devices Market Opportunities
- 4.3.1. Advancement in technology for more accurate and efficient hearing screening and diagnosis
5. Hearing Screening and Diagnostic Devices Market Porter's Five Forces Analysis
- 5.1. Bargaining Power of Suppliers
- 5.2. Bargaining Power of Consumers
- 5.3. Threat of New Entrants
- 5.4. Threat of Substitutes
- 5.5. Competitive Rivalry
6. Hearing Screening and Diagnostic Devices Market Layout
- 6.1. By Product
- 6.1.1. OAE/ABR Testing Devices
- 6.1.2. Audiometers
- 6.1.3. Otoscopes
- 6.1.4. Tympanometers
- 6.2. By Indication Type
- 6.2.1. Conductive Hearing Loss
- 6.2.2. Sensorineural Hearing Loss
- 6.2.3. Combination Hearing Loss
- 6.3. By End-User
- 6.3.1. Hospitals & Clinics
- 6.3.2. Diagnostic Centers
- 6.4. By Geography
- 6.4.1. North America
- 6.4.1.1. United States Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.1.2. Canada Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.1.3. Mexico Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.2. Europe
- 6.4.2.1. France Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.2.2. Germany Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.2.3. United Kingdom Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.2.4. Italy Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.2.5. Spain Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.2.6. Rest of Europe Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.3. Asia-Pacific
- 6.4.3.1. China Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.3.2. Japan Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.3.3. India Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.3.4. Australia Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.3.5. South Korea Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.3.6. Rest of Asia-Pacific Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.4. Rest of the World (RoW)
- 6.4.4.1. Middle East Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.4.2. Africa Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
- 6.4.4.3. South America Hearing Screening and Diagnostic Devices Market Size in USD million (2020-2028)
7. Hearing Screening and Diagnostic Devices Market Company and Product Profiles
- 7.1. Amplivox
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
- 7.2. Otodynamics Ltd.
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
- 7.3. INVENTIS s.r.l.
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
- 7.4. Intelligent Hearing Systems
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
- 7.5. Natus Medical Incorporated
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
- 7.6. MAICO Diagnostics
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
- 7.7. Path Medical Gmbh
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
- 7.8. Interacoustics A/S
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
- 7.9. Starkey Laboratories
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
- 7.10. Vivosonic Inc.
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
- 7.11. Welch Allyn
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
- 7.12. Grason-Stadler Inc.
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
- 7.13. Otometrics
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
- 7.14. MedRx
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
- 7.15. Medtronic
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy
8. KOL Views
9. Project Approach
10. DelveInsight Capabilities
11. About DelveInsight
12. Disclaimer & Contact Us
